Skip to Content
Merck

Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.

American journal of kidney diseases : the official journal of the National Kidney Foundation (2014-02-13)
Shreeram Akilesh, Noemie Juaire, Jeremy S Duffield, Kelly D Smith
ABSTRACT

Ifosfamide is a nitrogen mustard alkylating agent used as both a first-line and a salvage chemotherapeutic agent in the treatment of testicular germ cell tumors, various sarcomas, carcinomas, and some lymphomas. A well-known complication of ifosfamide therapy is transient acute kidney injury. However, in a minority of patients, the reduction in kidney function is progressive and permanent, sometimes occurring long after exposure to ifosfamide. Scattered reports have described the pathologic findings in kidneys permanently affected by ifosfamide toxicity. We present the findings of an illustrative case and review the pathology and molecular mechanisms of long-term ifosfamide toxicity with implications for personalized medicine.

MATERIALS
Product Number
Brand
Product Description

Ifosfamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ifosfamide, ≥98%